• Lyso-Tracker Red for Nanovaccine Trafficking

  2026-09-17

  Use Lyso-Tracker Red to convert nanovaccine trafficking into a measurable live-cell readout of acidic-compartment entry, retention, and apparent escape. This workflow complements immune-endpoint assays by connecting CLam/OVA particle design with dendritic-cell localization and lysosomal behavior.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Uses

  2026-09-17

  This dual-fluorescence reporter separates mRNA uptake from functional translation in one experiment. It enables quantitative nanoparticle validation, macrophage-delivery screening, trafficking studies, and faster optimization of gene-delivery workflows.

• Trifluoperazine 2HCl: From D2 to Host Defense

  2026-09-16

  Trifluoperazine 2HCl offers translational researchers a high-affinity dopamine D2 receptor probe for connecting dopaminergic signaling pathway modulation with emerging host-directed antibacterial research. This article examines the mechanistic rationale, experimental controls, evidence boundaries, and strategic opportunities for using the compound across neuropharmacology, immunology, and cancer-related models.

• GW 4869 (hydrochloride hydrate) for Reliable Assays

  2026-09-16

  Learn how GW 4869 (hydrochloride hydrate), SKU C4769, can support controlled studies of neutral sphingomyelinase, ceramide signaling, extracellular-vesicle release, and cell injury. This scenario-based guide connects formulation details with practical viability-assay controls and evidence from lupus nephritis research.

• FOLR3 Amplifies TGFβ Signaling in NASH Fibrosis

  2026-09-15

  This preprint identifies secreted folate receptor-gamma (FOLR3) as a human-associated driver of fibrogenesis in nonalcoholic steatohepatitis, linking its interaction with HTRA1 to enhanced TGFβ signaling in hepatic stellate cells. The findings suggest that FOLR3 may be both a fibrosis-associated biomarker and a mechanistic target, although species differences and the preprint status require careful interpretation.

• Calpeptin: Calpain Inhibitor for Fibrosis Research

  2026-09-15

  Calpeptin is a nanomolar calpain inhibitor with a reported IC50 of 5 nM for human calpain 1. Evidence supports its use in calpain, extracellular-vesicle, pulmonary fibrosis research, and fibrosis and inflammation modulation, but biochemical potency must not be treated as a universal cellular dose.

• 3X (DYKDDDDK) Peptide: From Tag to Assay Control

  2026-09-14

  The 3X (DYKDDDDK) Peptide is more than an epitope label: it can serve as a control element for purification, immunodetection, structural biology, and metal-sensitive assays. This article connects its assay utility with mechanistic lessons from nimbolide chemoproteomics and targeted protein degradation.

• In Vitro Drug Response Evaluation in Cancer

  2026-09-14

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability to separate growth inhibition from actual cancer-cell killing. This methodological framework improves interpretation of drug-response assays and provides a more rigorous basis for evaluating DNA repair–targeted agents in translational cancer research.

• Epacadostat (INCB024360) Whole-Blood Assays

  2026-09-13

  Epacadostat (INCB024360) connects nanomolar IDO1 inhibition with practical whole-blood cytokine, kynurenine, and T-cell function assays. This workflow guide shows how to separate direct enzymatic effects from donor, matrix, and checkpoint-combination variables in immuno-oncology research.

• Trametinib Resistance Biology: Designing Better Assays

  2026-09-12

  Trametinib and GSK1120212 enable precise MEK1/2 inhibition, but endpoint viability alone can conceal adaptive resistance. This guide translates multi-omics findings into resistance-aware assay design, pathway readouts, and practical oncology research workflows.

• Fingolimod (FTY720) for T-Cell Trafficking Assays

  2026-09-11

  Fingolimod (FTY720) offers a controlled way to perturb S1P-dependent lymphocyte distribution while researchers evaluate magnetic, antibody-guided T-cell engineering. This practical guide separates established MS and neurobiology evidence from exploratory tumor-immunology applications, with workflow parameters and troubleshooting safeguards.

• miR-424/503, CDC25A, and TGF-β Cell-Cycle Arrest

  2026-09-11

  The reference study identifies miR-424/503 as a posttranscriptional arm of TGF-β-induced cytostasis in mammary epithelial cells. By combining genetic, biochemical, reporter, and in vivo approaches, it shows that this microRNA cluster cooperates with transcriptional repression and protein degradation to lower CDC25A and enforce G1 arrest.

• 3X (DYKDDDDK) Peptide: Assay Logic

  2026-09-10

  The 3X (DYKDDDDK) Peptide supports selective protein capture and detection through a compact, hydrophilic FLAG epitope. This guide connects tag chemistry with assay controls, metal sensitivity, and evidence-based decisions for purification, immunodetection, and structural biology.

• X-press Tag Peptide: Purification Workflow

  2026-09-10

  The X-press Tag Peptide combines polyhistidine capture, Xpress epitope recognition, and enterokinase release in one N-terminal leader peptide. This article shows how to apply that architecture to recombinant protein purification, modification-focused assays, and troubleshooting workflows inspired by RHEB neddylation research.

• METTL16-SENP3-LTF Drives Ferroptosis Resistance in HCC

  2026-09-09

  Wang et al. identify a METTL16-SENP3-LTF regulatory axis that lowers the labile iron pool and protects hepatocellular carcinoma cells from ferroptosis. The study integrates epitranscriptomic regulation, SUMO-dependent protein stability, organoid and mouse models, and human tumor data to define a potential route for ferroptosis sensitization.

8061 records 1/538 page Next 12345 下5页 Last page